ADIPOQ and Insulin resistance: Adiponectin has been shown to directly affect HDL and TG metabolism, independent of fat mass, insulin resistance and dyslipidemia (33, 34) in non-psychiatric patients, and may modulate signaling pathways in response to inflammatory stimuli in several cell types (35).